Competitive intelligence on
small-molecule drugs and
the 90,000 global patents
|Title:||Rapidly disintegratable multiparticular tablet|
|Abstract:||Rapidly disintegratable multiparticulate tablet the excipient mixture of which is suitable for imparting a disintegration rate such that the tablet disintegrates in the mouth in an extremely short time, notably in less than sixty seconds, characterized by the fact that the active substance is present in the form of coated microcrystals or coated or uncoated microgranules.|
|Inventor(s):||Cousin; Gerard (Gallardon, FR), Bruna; Etienne (Chartres, FR), Gendrot; Edouard (Vernouillet, FR)|
|Assignee:||Laboratoires Prographarm (Chateauneuf, FR)|
Patent Claim Types:|
see list of patent claims
|Composition; Formulation; Dosage form; Use;|
|Foriegn Application Priority Data|
|Foreign Country||Foreign Patent Number||Foreign Patent Date|
|France||91 09245||Jul 22, 1991|
|Country||Document Number||Publication Date|
|World Intellectual Property Organization (WIPO)||9301805||Feb 04, 1993|
|South Korea||100197465||Jun 15, 1999|
|Japan||H06502194||Mar 10, 1994|
|Japan||2820319||Nov 05, 1998|
|China, Hong Kong S.A.R.||1007414||Apr 09, 1999|
|This preview shows a limited data set|
Subscribe for full access, or try a free trial
Export unavailable in trial.
Subscribe for complete access.
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.
Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided information. There is no warranty that the information contained herein is error free. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.